Advertisement
Advertisement
Coronavirus pandemic
Get more with myNEWS
A personalised news feed of stories that matter to you
Learn more
The new test is quicker and cheaper than nucleic acid tests. Photo: Xinhua

Chinese scientists confident new Covid-19 test can offer cheap, fast and effective alternative

  • The team from Wuhan University said the test has a higher accuracy rate than antigen tests and is quicker than nucleic acid tests
  • Rapid mass testing could help outbreaks by catching most cases quickly
Chinese scientists say they have designed a new Covid-19 test which is more reliable than antigen tests but is cheaper, faster and more convenient than nucleic tests.

Since the emergence of the highly infectious and fast spreading Omicron variant, the demand for a rapid and accurate Covid-19 test has become an essential strategy to contain the pandemic. Antigen tests, which have an accuracy rate of about 81 per cent, are commonly used for home testing.

However, they are only sensitive to specimens that come with a relatively high viral load, leaving it vulnerable for asymptomatic cases, according to Yin Hao of Wuhan University’s medical research institute who led the new research.

The researchers said the new test – known as sPAMC, or suboptimal protospacer adjacent motifs – has an accuracy rate of 94.2 per cent, according to a peer-reviewed paper published in the journal Nature Biomedical Engineering.

Chinese cleaner sleeps in public toilet in lockdown, cleans it for locals without loos

They wrote that it had detected 98 out of 104 coronavirus positive specimens among a total pool of 204 throat swab samples and the result can be generated in under 20 minutes, roughly the same time required for antigen tests and does not need the expensive equipment and skilled personnel required for PCR tests.

According to Yin, the new test offers a rapid, flexible and sensitive diagnostic solution that is critical in controlling the pandemic by capturing most infected cases.

Yin expects it will take about nine months to a year for the test to be approved for clinical use.

“Our challenge now is about finding ways to make the technology stable enough for mass clinical trials, mass and rapid production as well as good cost control,” Yin said.

The cost of sPAMC remains unknown as it depends on the supply chain and quality control but Yin believes it could be used in places like railway stations and airports.

04:19

Locked down in Shanghai: China’s biggest city grapples with its worst Covid outbreak since 2020

Locked down in Shanghai: China’s biggest city grapples with its worst Covid outbreak since 2020

“Nucleic tests require specimens to be delivered to a laboratory and it takes at least four hours to get a report, whereas sPAMC can be done in one-step without expensive laboratory equipment, making it suitable for fast and accurate detection,” Yin said.

As of this week, China has approved a total of 20 different Covid-19 antigen test products, according to People’s Daily.

02:23

China’s Jilin province remains Covid-19 epicentre of country’s latest pandemic wave

China’s Jilin province remains Covid-19 epicentre of country’s latest pandemic wave
China is currently battling a wave of cases that has seen parts of Shanghai being locked down. The city of nearly 25 million people recorded another rise in cases on Thursday, with 355 locally transmitted infections and 5,298 asymptomatic local cases.

Nationwide, China reported 8,454 local infections, including 1,803 cases in the northeastern province of Jilin.

21